Project Grant R01AG099141
- The National Institute on Aging awarded Kaiser Foundation Hospitals $2.495 million on September 15, 2025, under the Aging Research program (CFDA 93.866) to investigate missed home health care in older adults with Alzheimer's disease and related dementias. The project, titled "Missed Home Health Care in Older Adults with Dementia: Identifying Drivers, Outcomes, and Costs," uses mixed methods to identify correlates and drivers of missed home health care following hospital discharge,...
- The National Institute on Aging awarded Kaiser Foundation Hospitals $830,868 on September 3, 2026, under the Aging Research program (CFDA 93.866) to develop nonparametric methods integrating electronic health record and validated research data for aging-related scientific questions. Kaiser Foundation Research Institute will develop machine learning methods to improve accuracy and precision of inverse-probability weighted analyses and validation study design for causal inference and prediction...
- The National Institute of Environmental Health Sciences awarded Kaiser Foundation Hospitals $853,447 on September 1, 2026, under the Environmental Health program (CFDA 93.113) to examine long-term environmental dioxin exposure and cognitive and brain health outcomes in the Adult Changes in Thought Study. The research leverages existing data resources from ACT, a population-based prospective cohort study established in 1994 that follows cognitively healthy members aged 65 and older for incident...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded Kaiser Foundation Hospitals $663,216 on July 1, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to conduct a five-year study examining bone and muscle properties associated with fracture risk among persons living with HIV infection. The research leverages the Kaiser Permanente Southern California HIV Registry and electronic health records to compare bone, muscle, and body...
- The National Institute for Minority Health and Health Disparities awarded Kaiser Foundation Hospitals (Kaiser Permanente) $10.492 million on September 19, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307). The award funds a mixed-methods implementation science study examining racial and ethnic disparities in depression treatment and outcomes across five health systems in seven states (California, Texas, Georgia, Minnesota, Michigan, North Dakota, and...
- The National Institute of Allergy and Infectious Diseases awarded Kaiser Foundation Hospitals $825,617 on August 10, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to evaluate long-term effectiveness of recombinant zoster vaccine (RZV) against herpes zoster and postherpetic neuralgia. The award funds a longitudinal observational study assessing RZV effectiveness over time in real-world populations, addressing a gap in evidence where clinical trials have...
- The National Institute on Drug Abuse awarded Kaiser Foundation Hospitals $941,958 on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct longitudinal analysis of cannabis use trajectories across the lifespan. Kaiser's Kaiser Foundation Research Institute, based in Seattle, Washington, will use ten years of electronic health record data from its health system to model cannabis use patterns among more than 331,000 adult patients who completed a single-item...
- The National Institute on Alcohol Abuse and Alcoholism awarded Kaiser Foundation Hospitals $759,219 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct early identification research on alcohol-associated liver disease in primary care settings. Kaiser Foundation Hospitals, through its Kaiser Foundation Research Institute division, will recruit 1,300 patients to determine the prevalence of current liver disease using transient elastography across all AUDIT-C...
- The National Institute on Aging awarded $724,428 to Brigham & Women's Hospital Inc. on September 10, 2025, under the Aging Research program (CFDA 93.866) to fund a project grant evaluating the effect of a new Medicare dental benefit on the health of older adults. The project, led by Dr. Lisa Simon, MD DMD, an internal medicine physician and general dentist, will assess the impact of Medicare's 2023 dental coverage expansion on beneficiaries with eligible diagnoses including those...
- Summary The National Institute on Aging (NIA) awarded the University of Montana a $3.04 million Project Grant under the Aging Research program (CFDA 93.866) for a four-year project period extending from September 15, 2025, through September 14, 2029. The research investigates the role of neighborhood social exposome dynamics—encompassing social, psychosocial, and sociodemographic exposures at individual and contextual levels—in risk and resilience to Alzheimer's Disease and Related Dementias...
The National Institute on Aging awarded Kaiser Foundation Hospitals $825,851 on August 15, 2026, under the Aging Research program (CFDA 93.866) to investigate bi-directional associations between periodontitis, periodontal treatment, and Alzheimer's disease and related dementias in an integrated health system. The project will link detailed dental and medical electronic health records from over 80,000 Kaiser Permanente Northwest members to evaluate whether moderate or severe periodontitis is associated with incident ADRD and whether routine periodontal treatment is associated with reduced dementia incidence. For approximately 10,000 members, the research team will also integrate genetic and survey data from the Kaiser Permanente Research Bank to supplement electronic health record measures. The work is performed at Kaiser Permanente's location in Portland, Oregon 97227. The period of performance runs from the award date through May 31, 2031. Kaiser Foundation Hospitals, operating through its Kaiser Foundation Research Institute division and doing business as Kaiser Permanente, receives the award as a project grant, the standard assistance type for investigator-initiated biomedical research under the NIA's aging research portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $127.2k | 8/18/26 | ||
| Not listed | $698.7k | 8/12/26 |